HNRNPA2B1 and malignant colon neoplasm: To determine possible functions of hnRNPA2B1 in colon cancer, we used CRISPR/Cas9 directed gene editing to knockout hnRNPA2B1 expression in human colon cancer cell lines SW480 and HCT-116.